Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
McKesson
US Army
Cipla
Accenture
Medtronic
Cantor Fitzgerald
Fish and Richardson

Generated: April 19, 2018

DrugPatentWatch Database Preview

TRANCOPAL Drug Profile

« Back to Dashboard

Which patents cover Trancopal, and when can generic versions of Trancopal launch?

Trancopal is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in TRANCOPAL is chlormezanone. There is one drug master file entry for this compound. Additional details are available on the chlormezanone profile page.
Drug patent expirations by year for TRANCOPAL
Medical Subject Heading (MeSH) Categories for TRANCOPAL
Synonyms for TRANCOPAL
(-)-Chlormezanone
(-)-Fenarol
(.+/-.)-Chlormezanone
(.+/-.)-Fenarol
(+-)-Chlormezanone
(+-)-Fenarol
(+)-Chlormezanone
(+)-Fenarol
(+/-)-chlormezanone
102818-65-5
102818-66-6
102818-67-7
2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one
2-(4-Chlorophenyl)-3-methyl-1,3-thiazinan-4-one 1,1-dioxide
2-(4-Chlorophenyl)-3-methyl-1,3-thiazinan-4-one1,1-dioxide
2-(4-chlorophenyl)-3-methyl-1??,3-thiazinane-1,1,4-trione
2-(4-chlorophenyl)-3-methyl-1$l;{6},3-thiazinane-1,1,4-trione
2-(4-chlorophenyl)-3-methyl-1lambda,3-thiazinane-1,1,4-trione
2-(4-chlorophenyl)-3-methyl-1lambda6,3-thiazinane-1,1,4-trione
2-(4-Chlorophenyl)-3-methyl-4-metathiazanone-1,1-dioxide
2-(4-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide
2-(4-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one-1,1-dioxide
2-(4-Chlorophenyl)tetrahydro-3-methyl-4H,1,3-thiazin-4-one 1,1-Dioxide
2-(4-Chlorphenyl)-3-methyl-4-metathiazanon-1,1-dioxid
2-(p-Chlorophenyl)tetrahydro-3-methyl-4H-1,1-dioxide
2-(p-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide
2-(p-Chlorphenyl)-3-methyl-1,1-dioxide
2-(p-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide
2-(p-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-one, 1,1-dioxide
2-(para-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one, 1,1-dioxide
4BU37OM8KL
4H-1, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide
4H-1, 2-(p-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide, (-)-
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide, (+)-
4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-1,1-dioxide
4H-1,3-Thiazin-4-one, 2-(p-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide
4H-1,3-Thiazin-4-one, 2-(p-chlorophenyl)tetrahydro-3-methyl-, 1,1,-dioxide
4H-1,3-Thiazin-4-one, 2-(p-chlorophenyl)tetrahydro-3-methyl-1,1-dioxide
4H-1,3-Thiazin-4-one, tetrahydro-2-(p-chlorophenyl)-3-methyl-, 1,1-dioxide
80-77-3
AB00052410
AB00052410_04
AB00052410_05
AB2000427
AC1L1EB2
AK116027
AKOS000121464
Alinam
AN-42201
ANW-42456
Banabil-sintyal
Banabin
Banabin-sintyal
Banabin-syntyal
Biomol-NT_000277
Bisina
BPBio1_000409
BPBio1_001189
BRD-A20348246-001-05-9
BSPBio_000371
BSPBio_002728
C-192
C14WB33Y0S
CAS-80-77-3
CCG-39616
CHEBI:3619
CHEMBL1200714
Chlomedinon
Chlormethazanone
Chlormethazone
Chlormezanon
chlormezanona
chlormezanone
Chlormezanone (JAN/INN)
Chlormezanone (Trancopal)
Chlormezanone [BAN:INN:JAN]
Chlormezanone [INN:BAN:JAN]
Chlormezanone 1.0 mg/ml in Methanol
Chlormezanone, (-)-
Chlormezanone, (+)-
Chlormezanone(Trancopal)
Chlormezanonum
Chlormezanonum [INN-Latin]
Clorilax
Clormetazanone
Clormetazon
Clormezanona
Clormezanona [INN-Spanish]
Clormezanone
Clormezanone [DCIT]
CS-2399
CTK8B3394
D00268
D0S1OE
DB01178
Dichloromethazanone
Dichloromezanone
DivK1c_000886
dl-Chlormezanone
DSSTox_CID_2798
DSSTox_GSID_22798
DSSTox_RID_76732
DTXSID3022798
EINECS 201-307-4
EU-0100383
Fenaprim
FT-0623609
GTPL7323
HE019710
HE390868
HMS1569C13
HMS2096C13
HMS3261M07
HMS3266A22
HMS3655N09
HMS502M08
HSDB 3300
HY-B0353
I01-1903
IDI1_000886
InChI=1/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3
KB-222607
KBio1_000886
KBio2_000894
KBio2_003462
KBio2_006030
KBio3_001948
KBioGR_001734
KBioSS_000894
KS-000016RV
Lobak
Lopac0_000383
LP00383
LS-150535
MFCD00143951
Mio-sed
Miorilax
MLS003876813
MLS004773972
MolPort-003-666-762
Muskel
Muskel-Trancopal
Myolespen
NCGC00015191-03
NCGC00015191-04
NCGC00015191-05
NCGC00015191-06
NCGC00015191-07
NCGC00015191-08
NCGC00015191-09
NCGC00015191-10
NCGC00015191-13
NCGC00024597-02
NCGC00024597-03
NCGC00024597-04
NCGC00024597-05
NCGC00024597-06
NCGC00255305-01
NCGC00261068-01
NE32949
NINDS_000886
NSC 169108
NSC-169108
NSC-759569
NSC169108
NSC759569
Oprea1_275911
Pharmakon1600-02300062
Phenarol
Prestwick_736
Prestwick0_000336
Prestwick1_000336
Prestwick2_000336
Prestwick3_000336
Rexan
Rilansyl
Rilaquil
Rilasol
Rilassol
Rilax
Rillasol
s2021
SBI-0050370.P003
SCHEMBL217864
SMR001456219
SPBio_001793
SPBio_002292
Spectrum_000414
Spectrum2_001807
SPECTRUM2300062
Spectrum3_001084
Spectrum4_001237
Spectrum5_001364
SR-01000075208
SR-01000075208-1
ST24027544
Supotran
Suprotan
T5889171
Tanafol
Tox21_110093
Tox21_110093_1
Tox21_113151
Tox21_302197
Tox21_500383
TR-025493
Trancopa
TRANCOPAL (TN)
Trancote
Tranrilax
Transanate
UNII-4BU37OM8KL
UNII-C14WB33Y0S
WEQAYVWKMWHEJO-UHFFFAOYSA-
WEQAYVWKMWHEJO-UHFFFAOYSA-N
WIN 4692
WLN: T6VN DSWTJ B1 CR DG
Z271004890

US Patents and Regulatory Information for TRANCOPAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us TRANCOPAL chlormezanone TABLET;ORAL 011467-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us TRANCOPAL chlormezanone TABLET;ORAL 011467-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Accenture
Queensland Health
UBS
Merck
Cipla
Citi
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.